A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population

The induction of long-lived effector CD8(+) T cells is key to the development of efficient cancer vaccines. In this study, we demonstrated that a Toll-like receptor 2 (TLR2) agonist-fused antigen increased antigen presentation via TLR2 signaling and induced effector memory-like CD8(+) T cells agains...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Wu, Chiao-Chieh, Liu, Shih-Jen, Chen, Hsin-Wei, Shen, Kuan-Yin, Leng, Chih-Hsiang
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2016
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5058719/
https://ncbi.nlm.nih.gov/pubmed/27127171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items